Exercise could reduce bone tumor growth
(Medical Xpress)—Weight-bearing exercise, often prescribed to combat bone loss, might have anti-cancer effects. Cornell biomedical researchers report that mechanical stimulation of cancerous bone, in making ...
Cancer
May 07, 2013 |
5 / 5 (2) |
0
|
Blood test might help guide pancreatic cancer treatment
(HealthDay)—A simple blood test might help predict a pancreatic cancer patient's chances of benefiting from chemotherapy, a small study suggests.
Cancer
Jan 23, 2013 |
5 / 5 (1) |
0
|
Novel drug therapy targets aggressive form of non-Hodgkin's lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell – DLBCL ...
Cancer
Dec 10, 2012 |
not rated yet |
0
|
Existing drugs offer new treatment options for high-risk childhood leukemia subtype
Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies.
Cancer
Aug 13, 2012 |
not rated yet |
0
|
Nelarabine plus chemo viable in children with T-cell ALL
(HealthDay) -- Treatment of children with newly-diagnosed T-cell acute lymphoblastic leukemia (T-ALL) with nelarabine, in addition to an intensive Berlin-Frankfurt-Münster (BFM) 86-based chemotherapy ...
Cancer
Jun 29, 2012 |
not rated yet |
0
|
Studies help clarify the role of lapatinib and trastuzumab in treating HER2 positive breast cancer
In patients with HER2-positive breast cancer, Tykerb (lapatinib) has been used both in combination with herceptin (trastuzumab) and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy treatment. ...
Cancer
Jan 16, 2012 |
5 / 5 (2) |
0
|
Phase 3 trial finds no benefit from atrasentan added to chemo for advanced prostate cancer
A Data and Safety Monitoring Committee (DSMC) has determined that patients in a phase III clinical trial given atrasentan in addition to a standard chemotherapy regimen for advanced prostate cancer did not have longer survival ...
Cancer
Apr 21, 2011 |
not rated yet |
0
Cancer drug shortages mean higher costs and greater risk for patients
A national survey of health professionals showed that drug shortages are taking a heavy toll on cancer patients, forcing treatment changes and delays that for some patients meant worse outcomes, more therapy-related complications ...
Cancer
Mar 21, 2013 |
not rated yet |
0
Surgery and radiation improve survival for metastatic gastric cancer patients, study shows
Researchers at Moffitt Cancer Center studied patients with metastatic gastric cancer and found that those who have both surgery and radiation have better survival than those who receive one or no form of treatment.
Cancer
Feb 27, 2013 |
not rated yet |
0
Helping patients navigate new cancer drugs
As cancer treatment in pill form transforms how care is delivered, a new Michigan State University study underscores the challenges patients face in administering their own chemotherapy outside the supervised ...
Cancer
Jan 10, 2013 |
not rated yet |
0
E-mail prompts improve code status documentation
(HealthDay)—For patients with advanced lung cancer, prompting oncologists via e-mail successfully improved both the rate and timing of outpatient code status documentation in patients' electronic health ...
Cancer
Jan 05, 2013 |
not rated yet |
0
Intensified chemotherapy shows promise for children with very high risk form of leukemia
Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest the findings of a clinical ...
Cancer
Dec 10, 2012 |
not rated yet |
0
BRCA1 or BRCA2 mutation research may offer treatment option to certain patients
(Medical Xpress)—Ongoing research at the Methodist Cancer Center could reveal whether metastatic breast cancer patients with BRCA gene mutations are particularly responsive to a drug regimen that includes Veliparib, an ...
Cancer
Sep 20, 2012 |
not rated yet |
0
Prolonged dexamethasone cuts delayed nausea after chemo
(HealthDay) -- Adding dexamethasone to prochlorperazine on days two and three, following palonosetron and dexamethasone on day one, reduces delayed nausea (DN) in patients receiving chemotherapy containing ...
Cancer
Aug 22, 2012 |
not rated yet |
0
R-CHOP benefits older mantle-cell lymphoma patients
(HealthDay) -- In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) followed by maintenance ...
Cancer
Aug 09, 2012 |
not rated yet |
0
